Researchers Seek Pleural Effusions And Tissue to Create MCB Cell Lines
BOSTON, Mass--Under a grant from the US Army Breast Cancer Program, Harvard researchers are attempting to create medullary carcinoma of the breast (MCB) cell lines as part of their immunologic studies. There is currently only one line in the world for this infrequent tumor. "We are especially interested in pleural effusions (or ascites)--the best source to make cell lines--but will also use fresh, unfixed tumor tissue, and will pay all shipping costs," said investigator Richard Junghans, PhD, MD.
BOSTON, Mass--Under a grant from the US Army Breast Cancer Program,Harvard researchers are attempting to create medullary carcinomaof the breast (MCB) cell lines as part of their immunologic studies.There is currently only one line in the world for this infrequenttumor. "We are especially interested in pleural effusions(or ascites)--the best source to make cell lines--but will alsouse fresh, unfixed tumor tissue, and will pay all shipping costs,"said investigator Richard Junghans, PhD, MD.
Departments are asked to post the request, which remains in effectuntil January 1, 1998. Prior to thoracentesis, or, when possible,tumor excision, please call Dr. Junghans or Dr. P. Telleman at617-632-0943; fax: 617-632-0998. (The MCB cell line is from theArmed Forces Institute of Pathology, Atlas #67-1-42.)
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Elevating the Quality of Cancer Care via Cross-Department Collaboration
Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.
Artificial Intelligence in Cancer Care: Addressing Challenges and Health Equity
Artificial intelligence may mitigate overdiagnosis and unnecessary treatments in cancer cancer care by integrating with precision medicine.
